FIELD: biotechnology.
SUBSTANCE: invention relates to a composition of an anticancer vaccine for transdermal administration for use in inducing cellular immunity against cancer with overexpression of the WT1 gene. Above composition contains an effective amount of: Db126 peptide and a cyclooxygenase inhibitor selected from a group consisting of ethodolac, loxoprofen and/or a salt thereof, indometacin, aspirin, diclofenac, ketoprofen, celecoxib and valdecoxib.
EFFECT: invention enables efficient induction of cell-mediated immunity against cancer.
5 cl, 9 dwg, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICANCER VACCINE COMPOSITION CONTAINING PEPTIDE WT1 FOR TRANSDERMAL ADMINISTRATION | 2014 |
|
RU2685933C2 |
| ANTI-CANCER VACCINE PREPARATION CONTAINING PEPTIDE WT1 IN THE FORM OF A TRANSDERMAL INTRODUCTION TAPE | 2014 |
|
RU2697443C2 |
| VACCINE COMPOSITION AGAINST MALIGNANT TUMOR BASED ON PEPTIDE WT1 FOR MUCOSAL INTRODUCTION | 2014 |
|
RU2687026C2 |
| METHODS FOR INCREASING EFFECTIVENESS OF ANTITUMOUR IMMUNE RESPONSE | 2015 |
|
RU2689162C2 |
| TOLL-LIKE RECEPTOR 7 OR 8 AGONIST AND CHOLESTEROL COMPLEX AND ITS USE | 2020 |
|
RU2790702C1 |
| MEDICAMENT | 2016 |
|
RU2709015C2 |
| IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
| IMMUNOGENIC COMPOSITION, VACCINE COMPRISING SAME, KIT FOR PREPARING SAID COMPOSITION AND METHOD OF TREATING DISEASES ASSOCIATED WITH GASTRIN SECRETION PATHOLOGY | 2014 |
|
RU2664197C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPEUTIC REGIMENS BASED ON VACCINES | 2013 |
|
RU2737765C2 |
| MODULAR PARTICLES FOR IMMUNOTHERAPY | 2014 |
|
RU2672055C2 |
